Effect of (-)-α-Bisabolol on the Inflammatory Response in Systemic Infection Experimental Model in C57BL/6 Mice

• Published in: Inflammation 2020-02, Vol.43 (1), p.193-203
• Main Authors: Cavalcante, Heitor Augusto Otaviano, Silva-Filho, Saulo Euclides, Wiirzler, Luiz Alexandre Marques, Cardia, Gabriel Fernando Esteves, Uchida, Nancy Sayuri, Silva-Comar, Francielli Maria de Souza, Bersani-Amado, Ciomar Aparecida, Cuman, Roberto Kenji Nakamura
• Format: Article
• Language: English
• Subjects: Animals; Anti-Inflammatory Agents - pharmacology; Bacterial Load; Biomedical and Life Sciences; Biomedicine; Cecum; Cells, Cultured; Chemotaxis, Leukocyte - drug effects; Cytotoxicity; Disease Models, Animal; Disseminated infection; Essential oils; Female; Host-Pathogen Interactions; Immunology; Infections; Inflammation; Inflammation - immunology; Inflammation - metabolism; Inflammation - microbiology; Inflammation - prevention & control; Internal Medicine; Leukocytes (neutrophilic); Lung - drug effects; Lung - immunology; Lung - metabolism; Lung - microbiology; Mice, Inbred C57BL; Monocyclic Sesquiterpenes - pharmacology; Neutrophils - drug effects; Neutrophils - immunology; Neutrophils - metabolism; Neutrophils - microbiology; Nitric Oxide - metabolism; Original Article; Pathology; Peritoneum; Peritoneum - drug effects; Peritoneum - immunology; Peritoneum - metabolism; Peritoneum - microbiology; Peroxidase; Phagocytes; Phagocytosis - drug effects; Pharmacology/Toxicology; Rheumatology; Sepsis; Sepsis - drug therapy; Sepsis - immunology; Sepsis - metabolism; Sepsis - microbiology; Sesquiterpenes; Systemic diseases
• ISSN: 0360-3997; 1573-2576
• DOI: 10.1007/s10753-019-01109-8

(-)-α-Bisabolol (BISA) is an unsaturated monocyclic sesquiterpenes compound, mainly found in the essential oil of chamomile ( Matricaria chamomilla ). It has been reported that this compound has several biological activities, but there are few studies evaluating the activity of this compound in the systemic inflammatory response in infectious processes. The aim of this study was to evaluate the effect of BISA on the inflammatory response and survival rate in a systemic infection model, and in vitro neutrophils phagocytic activity. BISA at concentration of 3, 10, 30, and 90 μg/ml did not presented in vitro cytotoxicity in MTT assay, and at concentrations of 1 and 3 μg/ml the BISA treatment increased in vitro phagocytic neutrophil activity. For the inflammatory response study, we verified the BISA treatment effect in a cecal ligation and puncture (CLP)-induced systemic infection model in mice; in this model, we demonstrate that BISA at dose of 100 mg/kg reduced the leukocyte recruitment in peritoneal cavity; at dose of 200 mg/kg, the NO concentration was increased in the peritoneal cavity. The bacteria CFU number was reduced in mice blood in the BISA treatment, at doses of 100 and 200 mg/kg. The BISA treatment at doses of 50 and 100 mg/kg increased the myeloperoxidase activity and reduction NO production in lung tissue of mice in CLP model. At dose of 100 mg/kg, the BISA treatment was able to reduce the mortality rate of mice submitted to CLP-induced sepsis and observed for 7 days. The results suggest an effect of BISA on inflammatory response, with activity on leukocyte chemotactic and NO production, in addition to increasing the survival rate of animals submitted to CLP model.